Boxer Capital, LLC

Overview

• HeadquartersSan Diego, United States²
• Legal formLimited Liability Company²
• LEI254900B2ORVQ6WY0M041²
• StatusActive²
• LEI statusIssued and current²
• Registered addressC/O THE CORPORATION TRUST COMPANY, 19801 Wilmington, United States²
• Registered withDivision of Corporations, Department of State, 4053754²

See how the biggest companies compare on our leaderboards

Corporate structure

Boxer Capital, LLC sits at the top of its group. 31 entities, 4 countries on record. Switch between the flow chart and the network, and select any entity to see its details.

Built from parent and subsidiary links from GLEIF, the Global Legal Entity Identifier Foundation (CC0); stakes of 5% or more it reported on Schedules 13D and 13G (30 companies). Each entity in the chart links to its source.

Timeline

1. Nov 16, 2005Founded Boxer Capital, LLC is founded²

Filings

17 filings to the SEC since October 2021: 17 other. The latest 17:

1. Feb 14, 202513F-HR EDGAR
2. Nov 14, 202413F-HR EDGAR
3. Aug 28, 2024N-PX EDGAR
4. Aug 14, 202413F-HR EDGAR
5. May 15, 202413F-HR EDGAR
6. Feb 14, 202413F-HR EDGAR
7. Nov 14, 202313F-HR EDGAR
8. Aug 23, 2023144 EDGAR
9. Aug 14, 202313F-HR EDGAR
10. May 22, 2023144 EDGAR
11. May 15, 202313F-HR EDGAR
12. Feb 14, 202313F-HR EDGAR
13. Nov 14, 202213F-HR EDGAR
14. Aug 15, 202213F-HR EDGAR
15. May 16, 202213F-HR EDGAR
16. Feb 14, 202213F-HR EDGAR
17. Nov 15, 202113F-HR EDGAR

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Stakes it holds

Boxer Capital, LLC has told the SEC it owns more than 5% of 30 companies, latest first (Schedules 13D and 13G).

• Tango Therapeutics (United States)SC 13D/A Oct 15, 2024³
• Tyra Biosciences, Inc.SC 13D/A Jun 16, 2022 to Oct 15, 2024⁴
• iTeos Therapeutics, Inc.SC 13D/A Jan 6, 2022 to Oct 15, 2024⁵
• Instil Bio, Inc.SC 13G Sep 27, 2024⁶
• uniQure N.V.SC 13G Jul 18, 2024⁷
• Century Therapeutics (United States)SC 13G Apr 22, 2024⁸
• PMV Pharmaceuticals, Inc.SC 13G/A Feb 14, 2022 to Feb 14, 2024⁹
• Fate TherapeuticsSC 13G Feb 12, 2024¹⁰
• Mirati Therapeutics, Inc.SC 13D/A Aug 16, 2023 to Jan 25, 2024¹¹
• Nkarta Therapeutics (United States)SC 13G Jan 18, 2024¹²
• Rain Oncology Inc.SC 13D/A Nov 8, 2022 to Dec 18, 2023¹³
• Ideaya Biosciences (United States)SC 13G/A Feb 14, 2023¹⁴
• Milestone Pharmaceuticals Inc.SC 13G/A Feb 14, 2022 to Feb 14, 2023¹⁵
• SpringWorks Therapeutics, Inc.SC 13G Sep 19, 2022¹⁶
• Atreca, Inc.SC 13G/A Feb 14, 2022¹⁷
• Biomea Fusion, Inc.SC 13G/A Feb 14, 2022¹⁸
• Cabaletta Bio, Inc.SC 13G/A Feb 14, 2022¹⁹
• CymaBay Therapeutics (United States)SC 13G/A Feb 14, 2022²⁰
• DBV TechnologiesSC 13G/A Feb 14, 2022²¹
• Elevation Oncology, Inc.SC 13G/A Feb 14, 2022²²
• F-star Therapeutics, Inc.SC 13G/A Feb 14, 2022²³
• Marinus Pharmaceuticals (United States)SC 13G/A Feb 14, 2022²⁴
• Matinas BioPharma Holdings, Inc.SC 13G/A Feb 14, 2022²⁵
• Mereo BioPharma Group plcSC 13G/A Feb 14, 2022²⁶
• Merus N.V.SC 13G/A Feb 14, 2022²⁷
• POINT Biopharma Global Inc.SC 13G/A Feb 14, 2022²⁸
• Silverback TherapeuticsSC 13G/A Feb 14, 2022²⁹
• Solid Biosciences Inc.SC 13G/A Feb 14, 2022³⁰
• Talis Biomedical CorpSC 13G/A Feb 14, 2022³¹
• Odonate Therapeutics, Inc.SC 13D/A Nov 22, 2021 to Nov 26, 2021³²